Survival of chemo-radiotherapy-treated and thermotherapy-treated patients with unresectable lung cancer.
Prognosis and survival of unresectable lung cancer patients is poor. The 5-year survival varies from 3 to 15% without relevant differences between treated and non-treated patients. The 2-year survival of comparable patients treated with chemo-radiotherapy (CH-RT) (n=63) and thermotherapy (RFT) (n=40) was studied. The 2-year follow-up survival curves did not differ for the groups in general but the survival time was longer for stage IV and non-small cell lung cancer in the RFT-group (13.2 mo and 13.4 mo, respectively) compared with CH-RT-group (8.4 mo and 9.6 mo, respectively). The difference was highly statistically significant (p<0.005).
Rizzo
S
S
Division of Pneumology, IRCCS, Policlinico S. Matteo, Pavia, I-27100, Italy.
D000368:Aged; D002289:Carcinoma, Non-Small-Cell Lung / Q000401:mortality* / Q000473:pathology / Q000628:therapy; D018288:Carcinoma, Small Cell / Q000401:mortality* / Q000473:pathology / Q000628:therapy; D003131:Combined Modality Therapy; D004358:Drug Therapy; D005260:Female; D006801:Humans; D006979:Hyperthermia, Induced; D008175:Lung Neoplasms / Q000401:mortality* / Q000473:pathology / Q000628:therapy; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D011446:Prospective Studies; D011878:Radiotherapy; D015996:Survival Rate; D016896:Treatment Outcome